Adam Craig, EVP, Development & CMO at Viracta Therapeutics, holds 376.09K shares in X4 Pharmaceuticals (Ticker: XFOR), holds 0.00 shares in CTI BioPharma (Ticker: CTIC), holds 23.45K shares in Viracta Therapeutics (Ticker: VIRX). Most recently, Adam Craig Bought ― shares of X4 Pharmaceuticals on Oct 27, 2025 for an estimated value of $250.00K.
What is the percentage of profitable transactions made by Adam Craig?
The percentage of profitable transactions made by Adam Craig is ―.
What is the average return per transaction made by Adam Craig?
The average return per transaction made by Adam Craig is ―.
What stocks does Adam Craig hold?
Adam Craig holds: VIRX, CTIC, XFOR stocks.
What was Adam Craig’s latest transaction?
Adam Craig latest transaction was an Informative Buy of $250.00K.
What was Adam Craig's most profitable transaction?
Adam Craig’s most profitable transaction was an Informative Buy of CTIC stock on December 2, 2021. The return on the trade was 315.90%.
What is Adam Craig's role in Viracta Therapeutics?
Adam Craig's role in Viracta Therapeutics is EVP, Development & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.